SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-22-013078 to Ping An Biomedical Co., Ltd. (PASW)

Ping An Biomedical Co., Ltd.
Date: Dec. 5, 2022 · CIK: 0001897532 · Accession: 0000000000-22-013078

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

Date
December 5, 2022
Author
Not clearly detected
Form
UPLOAD
Company
Ping An Biomedical Co., Ltd.

Letter

United States securities and exchange commission logo December 5, 2022 Suqin Li Chief Executive Officer Majestic Ideal Holdings Ltd 22/F, China United Plaza 1002-1008, Tai Nan West Street Cheung Sha Wan, Kowloon, Hong Kong Re:Majestic Ideal Holdings Ltd Amendment No. 7 to Draft Registration Statement on Form F-1 Submitted November 23, 2022 CIK No. 0001897532 Dear Suqin Li: We have reviewed your amended draft registration statement and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter by providing the requested information and either submitting an amended draft registration statement or publicly filing your registration statement on EDGAR. If you do not believe our comments apply to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing the information you provide in response to these comments and your amended draft registration statement or filed registration statement, we may have additional comments. Amendment No. 7 to Draft Registration Statement on Form F-1 submitted November 23, 2022 Compensation of Directors and Executive Officers, page 94 1.Please update your compensation disclosure for your recently completed fiscal year ended September 30, 2022.

FirstName LastNameSuqin Li Comapany NameMajestic Ideal Holdings Ltd December 5, 2022 Page 2 FirstName LastName Suqin Li Majestic Ideal Holdings Ltd December 5, 2022 Page 2 You may contact Heather Clark at 202-551-3624 or Kevin Woody at 202-551-3629 if you have questions regarding comments on the financial statements and related matters. Please contact Thomas Jones at 202-551-3602 or Jay Ingram at 202-551-3397 with any other questions. Sincerely, Division of Corporation Finance Office of Manufacturing cc: Lawrence S. Venick, Esq.

Show Raw Text
United States securities and exchange commission logo
December 5, 2022
Suqin Li
Chief Executive Officer
Majestic Ideal Holdings Ltd
22/F, China United Plaza
1002-1008, Tai Nan West Street
Cheung Sha Wan, Kowloon, Hong Kong
Re:Majestic Ideal Holdings Ltd
Amendment No. 7 to Draft Registration Statement on Form F-1
Submitted November 23, 2022
CIK No. 0001897532
Dear Suqin Li:
            We have reviewed your amended draft registration statement and have the following
comments.  In some of our comments, we may ask you to provide us with information so we
may better understand your disclosure.
            Please respond to this letter by providing the requested information and either submitting
an amended draft registration statement or publicly filing your registration statement on
EDGAR.  If you do not believe our comments apply to your facts and circumstances or do not
believe an amendment is appropriate, please tell us why in your response.
            After reviewing the information you provide in response to these comments and your
amended draft registration statement or filed registration statement, we may have additional
comments.
Amendment No. 7 to Draft Registration Statement on Form F-1 submitted November 23, 2022
Compensation of Directors and Executive Officers, page 94
1.Please update your compensation disclosure for your recently completed fiscal year ended
September 30, 2022.

 FirstName LastNameSuqin Li
 Comapany NameMajestic Ideal Holdings Ltd
 December 5, 2022 Page 2
 FirstName LastName
Suqin Li
Majestic Ideal Holdings Ltd
December 5, 2022
Page 2
            You may contact Heather Clark at 202-551-3624 or Kevin Woody at 202-551-3629 if
you have questions regarding comments on the financial statements and related matters.  Please
contact Thomas Jones at 202-551-3602 or Jay Ingram at 202-551-3397 with any other questions.
Sincerely,
Division of Corporation Finance
Office of Manufacturing
cc:       Lawrence S. Venick, Esq.